trilostane has been researched along with Congenital Adrenal Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M | 1 |
1 other study(ies) available for trilostane and Congenital Adrenal Hyperplasia
Article | Year |
---|---|
Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor).
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Dehydroepiandrosterone; Desoxycorticosterone; Dihydrotestosterone; Estradiol; Female; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Male; Middle Aged; Oxidative Phosphorylation Coupling Factors; Progesterone; Radioimmunoassay; Renin-Angiotensin System; Testosterone | 1985 |